Dr. Gandhi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton Streets RPCI Clinical Practice Plan
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-898-3279
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2015 - 2018- University at BuffaloResidency, Internal Medicine, 2012 - 2015
Lady Hardinge Medical CollegeClass of 2011
Certifications & Licensure
NY State Medical License 2015 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer Start of enrollment: 2019 Jan 09
- Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer Start of enrollment: 2019 Dec 06
- Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer Start of enrollment: 2022 Dec 19
- Join now to see all
Publications & Presentations
PubMed
- 6 citationsIntratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.Rongrong Wu, Shipra Gandhi, Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi
Breast Cancer Research and Treatment. 2022-08-01 - 9 citationsConflicting roles of EGFR expression by subtypes in breast cancer.Masanori Oshi, Shipra Gandhi, Yoshihisa Tokumaru, Li Yan, Akimitsu Yamada
American Journal of Cancer Research. 2021-10-15 - 19 citationsMELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.Masanori Oshi, Shipra Gandhi, Michelle R Huyser, Yoshihisa Tokumaru, Li Yan
American Journal of Cancer Research. 2021-01-01
Press Mentions
The HR-Positive Breast Cancer Treatment Paradigm Sits on the Cusp of Significant ShiftsSeptember 12th, 2024- Benefit of Chemotherapy for Patients with Early-Stage Breast Cancer Varies by Tumor AnatomyMay 10th, 2023
- Stress Receptors Explored as Possible Immune Checkpoint, Suggesting Role for Beta-Blockers in Cancer TreatmentApril 11th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
